Charles S. Ryan - 01 Sep 2023 Form 3 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
President
Signature
/s/ Brendan Hannah, Attorney-in-Fact for Charles S. Ryan, Ph.D.
Issuer symbol
QNCX
Transactions as of
01 Sep 2023
Net transactions value
$0
Form type
3
Filing time
06 Sep 2023, 17:40:13 UTC
Next filing
02 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding QNCX Common Stock 74,074 01 Sep 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.